Discover
RANI
Rani Therapeutics Holdings, Inc.
0.59
9 x 0.76
2 x 1.00
bid
ask
-
0.02
2.54%
6 @ 04:00 PM
0.59 +0.00 (0.00%)
| Ytd | -56.30% | |
| 1y | -59.31% |
0.57
day range
0.61
0.57
52 week range
2.63
| Open | 0.60 | Prev Close | 0.61 | Low | 0.57 | High | 0.61 | Mkt Cap | 82.91M |
| Vol | 676.29K | Avg Vol | 590.62K | EPS | -0.15 | P/E | N/A | Forward P/E | -1.41 |
| Beta | 0.11 | Short Ratio | 0.36 | Inst. Own | 19.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 0.77 | 200-d Avg | 0.94 | 1yr Est | 11.50 |
| Income Statement | |||
| Total Revenue | 1.71M | ||
| Revenues (USD) | 1.71M | ||
| Gross Profit | 1.71M | ||
| Operating Expenses | 10.54M | ||
| Research and Development Expense | 5.02M | ||
| Selling, General and Administrative Expense | 5.52M | ||
| Operating Income | -8.83M | ||
| Interest Expense | 8.00K | ||
| Net Income | -7.39M | ||
| Net Income Common Stock | -7.39M | ||
| Net Income Common Stock (USD) | -7.39M | ||
| Consolidated Income | -8.42M | ||
| Net Income to Non-Controlling Interests | -1.03M | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -7.38M | ||
| Earning Before Interest & Taxes (USD) | -7.38M | ||
| Weighted Average Shares | 187.17M | ||
| Weighted Average Shares Diluted | 187.17M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.87M | ||
| Cash and Equivalents (USD) | 4.87M | ||
| Investments | 48.52M | ||
| Investments Current | 48.52M | ||
| Trade and Non-Trade Receivables | 2.04M | ||
| Current Assets | 56.52M | ||
| Property, Plant & Equipment Net | 4.07M | ||
| Total Assets | 60.84M | ||
| Debt Current | 1.33M | ||
| Total Debt | 3.55M | ||
| Current Liabilities | 10.64M | ||
| Debt Non-Current | 2.22M | ||
| Total Liabilities | 12.86M | ||
| Accumulated Retained Earnings (Deficit) | -147.00M | ||
| Accumulated Other Comprehensive Income | -30.00K | ||
| Shareholders Equity | 39.23M | ||
| Shareholders Equity (USD) | 39.23M | ||
| Assets Non-Current | 4.32M | ||
| Total Debt (USD) | 3.55M | ||
| Deferred Revenue | 5.12M | ||
| Liabilities Non-Current | 2.22M | ||
| Trade and Non-Trade Payables | 1.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 629.00K | ||
| Net Cash Flow from Financing | 18.81M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.78M | ||
| Capital Expenditure | -32.00K | ||
| Issuance (Purchase) of Equity Shares | 18.82M | ||
| Net Cash Flow from Investing | -14.56M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -14.52M | ||
| Net Cash Flow from Operations | -9.03M | ||
| Share Based Compensation | 2.42M | ||